110 related articles for article (PubMed ID: 38113630)
1. Shen Qi Wan ameliorates nephritis in chronic kidney disease via AQP1 and DEFB1 regulation.
Liu Y; Hong X; Liu L; Li X; Huang S; Luo Q; Huang Q; Qiu J; Qiu P; Li C
Biomed Pharmacother; 2024 Jan; 170():116027. PubMed ID: 38113630
[TBL] [Abstract][Full Text] [Related]
2. Shen Qi Wan attenuates renal interstitial fibrosis through upregulating AQP1.
Lin Y; Wei J; Zhang Y; Huang J; Wang S; Luo Q; Yu H; Ji L; Zhou X; Li C
Chin J Nat Med; 2023 May; 21(5):359-370. PubMed ID: 37245874
[TBL] [Abstract][Full Text] [Related]
3. The Effect of Shen Qi Wan Medicated Serum on NRK-52E Cells Proliferation and Migration by Targeting Aquaporin 1 (AQP1).
He Y; Bao YT; Chen HS; Chen YT; Zhou XJ; Yang YX; Li CY
Med Sci Monit; 2020 Jun; 26():e922943. PubMed ID: 32491998
[TBL] [Abstract][Full Text] [Related]
4. The Protective Effect of Shen Qi Wan on Adenine-Induced Podocyte Injury.
Lin Y; Zhang J; Fu Y; Ji L; Lin L; Chen H; Yang Y; Li C
Evid Based Complement Alternat Med; 2020; 2020():5803192. PubMed ID: 33273954
[TBL] [Abstract][Full Text] [Related]
5. Shen Qi Wan-Containing Serum Alleviates Renal Interstitial Fibrosis via Restraining Notch1-Mediated Epithelial-Mesenchymal Transition.
Chen H; Zhou X; Yang Y; Feng Y
Evid Based Complement Alternat Med; 2023; 2023():3352353. PubMed ID: 36793762
[TBL] [Abstract][Full Text] [Related]
6. Target Identification of Active Constituents of
Zhang JY; Hong CL; Chen HS; Zhou XJ; Zhang YJ; Efferth T; Yang YX; Li CY
Front Pharmacol; 2019; 10():650. PubMed ID: 31275142
[No Abstract] [Full Text] [Related]
7. Aquaporin-1 attenuates macrophage-mediated inflammatory responses by inhibiting p38 mitogen-activated protein kinase activation in lipopolysaccharide-induced acute kidney injury.
Li B; Liu C; Tang K; Dong X; Xue L; Su G; Zhang W; Jin Y
Inflamm Res; 2019 Dec; 68(12):1035-1047. PubMed ID: 31529146
[TBL] [Abstract][Full Text] [Related]
8. Shen Qi Wan Ameliorates Learning and Memory Impairment Induced by STZ in AD Rats through PI3K/AKT Pathway.
Huang J; Xu Z; Chen H; Lin Y; Wei J; Wang S; Yu H; Huang S; Zhang Y; Li C; Zhou X
Brain Sci; 2022 Jun; 12(6):. PubMed ID: 35741643
[TBL] [Abstract][Full Text] [Related]
9. Fufang Shenhua tablet inhibits renal fibrosis by inhibiting PI3K/AKT.
Li R; Shi C; Wei C; Wang C; Du H; Liu R; Wang X; Hong Q; Chen X
Phytomedicine; 2023 Jul; 116():154873. PubMed ID: 37257328
[TBL] [Abstract][Full Text] [Related]
10. Investigation of the mechanism of Shen Qi Wan prescription in the treatment of T2DM via network pharmacology and molecular docking.
Zhao P; Zhang X; Gong Y; Li W; Wu Z; Tang Y; Liu G
In Silico Pharmacol; 2022; 10(1):9. PubMed ID: 35673584
[TBL] [Abstract][Full Text] [Related]
11. Suo Quan Wan ameliorates bladder overactivity and regulates neurotransmission via regulating Myosin Va protein expression.
Zhang Y; Zhang J; Hong M; Huang J; Xu S; Wang R; Zhou N; Huang P; Tan B; Cao H
Phytomedicine; 2022 Sep; 104():154265. PubMed ID: 35763954
[TBL] [Abstract][Full Text] [Related]
12. Fisetin ameliorates fibrotic kidney disease in mice via inhibiting ACSL4-mediated tubular ferroptosis.
Wang B; Yang LN; Yang LT; Liang Y; Guo F; Fu P; Ma L
Acta Pharmacol Sin; 2024 Jan; 45(1):150-165. PubMed ID: 37696989
[TBL] [Abstract][Full Text] [Related]
13. Aquaporin 1 alleviates acute kidney injury via PI3K-mediated macrophage M2 polarization.
Liu C; Li B; Tang K; Dong X; Xue L; Su G; Jin Y
Inflamm Res; 2020 May; 69(5):509-521. PubMed ID: 32179955
[TBL] [Abstract][Full Text] [Related]
14. Thalidomide suppresses inflammation in adenine-induced CKD with uraemia in mice.
Santana AC; Degaspari S; Catanozi S; Dellê H; de Sá Lima L; Silva C; Blanco P; Solez K; Scavone C; Noronha IL
Nephrol Dial Transplant; 2013 May; 28(5):1140-9. PubMed ID: 23345625
[TBL] [Abstract][Full Text] [Related]
15. Multi-omics approaches revealed the therapeutic mechanisms of Suo-Quan-Wan for treating overactive bladder in spontaneously hypertensive rats.
Sun Z; Tie Y; Tong X; Cheng M; Wu Y; Xu P; Xue M; Xu L; Zhou X
J Ethnopharmacol; 2024 Jan; 318(Pt B):117066. PubMed ID: 37604331
[TBL] [Abstract][Full Text] [Related]
16. Aquaporin-1 translocation and degradation mediates the water transportation mechanism of acetazolamide.
Zhang J; An Y; Gao J; Han J; Pan X; Pan Y; Tie L; Li X
PLoS One; 2012; 7(9):e45976. PubMed ID: 23029347
[TBL] [Abstract][Full Text] [Related]
17. Aquaporin-1 retards renal cyst development in polycystic kidney disease by inhibition of Wnt signaling.
Wang W; Li F; Sun Y; Lei L; Zhou H; Lei T; Xia Y; Verkman AS; Yang B
FASEB J; 2015 Apr; 29(4):1551-63. PubMed ID: 25573755
[TBL] [Abstract][Full Text] [Related]
18. Withaferin A protects against endoplasmic reticulum stress-associated apoptosis, inflammation, and fibrosis in the kidney of a mouse model of unilateral ureteral obstruction.
Chen CM; Chung YP; Liu CH; Huang KT; Guan SS; Chiang CK; Wu CT; Liu SH
Phytomedicine; 2020 Dec; 79():153352. PubMed ID: 33007732
[TBL] [Abstract][Full Text] [Related]
19. Prediction of the mechanisms of action of Shenkang in chronic kidney disease: A network pharmacology study and experimental validation.
Qin T; Wu L; Hua Q; Song Z; Pan Y; Liu T
J Ethnopharmacol; 2020 Jan; 246():112128. PubMed ID: 31386888
[TBL] [Abstract][Full Text] [Related]
20. Lindera aggregata intervents adenine-induced chronic kidney disease by mediating metabolism and TGF-β/Smad signaling pathway.
Cai H; Wang J; Luo Y; Wang F; He G; Zhou G; Peng X
Biomed Pharmacother; 2021 Feb; 134():111098. PubMed ID: 33341058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
